Form CORRESP - Correspondence:
SEC Accession No. 0001558370-23-019519
Filing Date
2023-12-06
Accepted
2023-12-06 16:22:30
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 9378
  Complete submission text file 0001558370-23-019519.txt   10600
Mailing Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Filer) CIK: 0000812796 (see all company filings)

EIN.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)